Nazione: Svizzera
Lingua: italiano
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
metformini hydrochloridum, sitagliptinum
Spirig HealthCare AG
A10BD07
metformini hydrochloridum, sitagliptinum
Compresse a Rilascio modificati
metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), E 172 (rubrum), pro compresso, natrium 2.10 mg.
B
Synthetika
Antidiabetico
zugelassen
2023-08-03